Sale of a Utility-Ready Biologics / Vaccines Manufacturing Site
PharmaBioSource provided transaction consulting services to Shire on the divestment of its 340,000 SF Krems, Austria vaccines manufacturing site to Merck Animal Health.
- Service: Transaction Consulting
- Sector: Biotechnology / Animal Health
- Sub-sector: Vaccines
- Engagement Type: Sell Side
PharmaBioSource provided comprehensive transaction services to divest Shire’s biologics / vaccines manufacturing site near Vienna, Austria. The site was acquired by Merck Animal Health to expand its global vaccine manufacturing capacity.
PharmaBioSource’s services included a benchmark valuation, buyer target identification, creation of the confidential information memorandum (CIM), data room development and due diligence support.